The 2014 U.S. venture capital (VC) landscape indicates a rebound in fundraising and investment activity, with $29 billion invested, primarily in software and biotech sectors. While earlier stage investments have declined, expansion stage financing is increasing, reflecting shifts in investor focus. The exit market is strong, with high levels of IPOs and M&A activity, leading to robust returns for limited partners.